Brief: Aditxt Subsidiary Adimune Announces Positive Results From Mayo Clinic Pre-Clinical Studies To Support FDA And European Regulatory Submissions For Type 1 Diabetes, Psoriasis, And Stiff Person Syndrome Human Trials

Aditxt

14/04/2025 14:24

April 14 (Reuters) - Aditxt Inc ADTX.O:

ADITXT SUBSIDIARY ADIMUNE ANNOUNCES POSITIVE RESULTS FROM MAYO CLINIC PRE-CLINICAL STUDIES TO SUPPORT FDA AND EUROPEAN REGULATORY SUBMISSIONS FOR TYPE 1 DIABETES, PSORIASIS, AND STIFF PERSON SYNDROME HUMAN TRIALS

Source text: ID:nBw778m9ra

Further company coverage: ADTX.O

 ((Reuters.Briefs@thomsonreuters.com;))